Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q4 2016 value amounting to 4203.05%.

  • Rocket Pharmaceuticals' EBITDA Margin changed N/A to 4203.05% in Q4 2016 from the same period last year, while for Sep 2017 it was 1704.76%, marking a year-over-year change of. This contributed to the annual value of 1658.21% for FY2015, which is 8720900.0% up from last year.
  • Rocket Pharmaceuticals' EBITDA Margin amounted to 4203.05% in Q4 2016.
  • In the past 5 years, Rocket Pharmaceuticals' EBITDA Margin ranged from a high of 4850.24% in Q1 2016 and a low of 2042.48% during Q3 2016